IVVD - NASDAQ

Invivyd, Inc.

IVVD·NASDAQ

$1.13

+1.5%

HealthcareBiotechnology

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$150.25M

EPS-0.3000

P/E Ratio-3.77

Earnings Date08/13/2026

ivvd

Additional Paid-In Capital

Last Annual Value

1.20B

3-Year CAGR

10%

5-Year CAGR

500%

10-Year CAGR

145%

Adjust for Inflation

Invivyd, Inc. Competitors Analysis of Additional Paid-In Capital

IVVD · NASDAQ

Company	Additional Paid-In Capital	CAGR 3Y	CAGR 5Y	CAGR 10Y
Invivyd, Inc. NASDAQ:IVVD	1.20B	9.6%	7.1%	N/A
OmniAb, Inc. NASDAQ:OABI	433.18M	7.0%	N/A	N/A
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	345.84M	18.2%	16.8%	29.8%
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	702.98M	17.8%	10.9%	32.5%
Pyxis Oncology, Inc. NASDAQ:PYXS	496.47M	6.4%	7.1%	N/A
Cassava Sciences, Inc. NASDAQ:SAVA	0.00	N/A	N/A	N/A
Vor Biopharma Inc. NASDAQ:VOR	988.60M	26.3%	23.3%	N/A
Sangamo Therapeutics, Inc. NASDAQ:SGMO	1.61B	2.6%	3.8%	10.8%
Neonc Technologies Holdings, Inc. NASDAQ:NTHI	97.95M	58.2%	40.2%	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	995.22M	8.7%	8.6%	N/A
Insight Molecular Diagnostics Inc. NASDAQ:IMDX	0.00	N/A	N/A	N/A

Invivyd, Inc. Fair Value Envelope

IVVD · NASDAQ

Our analysis suggests that IVVD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.132, this represents a potential HIDDEN relative to our calculated worth for Invivyd, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.132

Related Guides

Blog Categories

Continue your IVVD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.